Aptuit, LLC has relocated its recently acquired subsidiary Kuecept to its Oxford UK site, and added further formulation and safety assessment capacity for IND de-risking and enabling packages.   Kuecept provides phase appropriate pre-formulation testing, preclinical dose-vehicle screening and formulation development. Kuecept has expertise in respiratory, parenteral and oral formulation development and offers formulation rescue consultancy for moving challenging APIs through IND/CTA enabling sa...